ArticleNeurology. Clinical practice2016
Tocilizumab-associated multifocal cerebral thrombotic microangiopathy.
Article in Neurology. Clinical practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review.Frontiers in psychiatry · 2020Pooled it
- Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC).Biomedicines · 2023Review
- Outcomes of multiple sclerosis patients admitted with COVID-19 in a large veteran cohort.Multiple sclerosis and related disorders · 2022Article
- Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study.Antibiotics (Basel, Switzerland) · 2022Article
- Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis.Cureus · 2021Article
- Article
- Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology.Frontiers in cardiovascular medicine · 2021Review
- Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.Frontiers in molecular biosciences · 2021Review
- A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome.Cureus · 2020Article
- Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.European journal of neurology · 2020Review
- Case Report: Acute Thrombotic Microangiopathy in a Patient with STING-Associated Vasculopathy with Onset in Infancy (SAVI).Journal of clinical immunology · 2020Article
- Pathophysiological Mechanisms and Neurological Manifestations in COVID-19.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2020Article
- Pulmonary Embolism and Increased Levels of D-Dimer in Patients with Coronavirus Disease.Emerging infectious diseases · 2020Article
- Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.JAMA neurology · 2020Review
- Comorbidity Assessment Is Essential During COVID-19 Treatment.Frontiers in physiology · 2020Article
- Neurological manifestations in COVID-19: A narrative review.SAGE open medicine · 2020Review
- Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.Frontiers in neurology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.